Immediate Impact

1 by Nobel laureates 2 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
2 intermediate papers

Works of Andreas Lindauer being referenced

Using Model-Based “Learn and Confirm” to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial
2016
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
2009

Author Peers

Author Last Decade Papers Cites
Andreas Lindauer 498 183 17 150 18 756
W. David McGuinn 346 253 28 66 17 929
Nicola Dobbs 374 363 54 117 26 890
Zaina T. Al-Salama 252 312 15 87 35 956
Montgomery Ja 229 279 19 73 18 672
Griswold Dp 492 340 26 57 19 878
W R Laster 273 352 44 163 40 863
M. Ravic 387 289 12 77 36 951
Toshiyuki Isoe 383 617 11 156 29 921
Pierre Bischoff 331 444 22 219 39 984
Diane E. Gingrich 248 343 4 224 25 666

All Works

Loading papers...

Rankless by CCL
2026